Skip to main content
OpenTrials

Clinical trial condition

Squamous Cell Carcinoma of Head and Neck

Explore clinical trials studying Squamous Cell Carcinoma of Head and Neck. Study availability and eligibility vary by location and protocol.

1,365 public trials 360 recruiting studies
Refine in advanced search Browse all conditions

Squamous Cell Carcinoma of Head and Neck trial results

Active, Not Recruiting

A Study Evaluating AB248 Alone or in Combination With Pembrolizumab in Adult Patients With Solid Tumors

NCT05653882

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • City of Hope Duarte, California, United States
  • UCLA Los Angeles, California, United States
  • UCSD San Diego, California, United States
  • UCSF San Francisco, California, United States
View all 20 locations
View Trial Details
Active, Not Recruiting

Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT06082167

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Exelixis Clinical Site #2 Fullerton, California, United States
  • Exelixis Clinical Site #1 Orange City, Florida, United States
  • Exelixis Clinical Site #163 Tampa, Florida, United States
  • Exelixis Clinical Site #123 Athens, Georgia, United States
View all 168 locations
View Trial Details
Active, Not Recruiting

Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma

NCT02984410

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +14 more
Locations
  • CHU-UCL Namur - CHU Mont Godinne Namur, Yvoir, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Institut Jules Bordet-Hopital Universitaire ULB Brussels, Belgium
  • U.Z. Leuven - Campus Gasthuisberg Leuven, Belgium
View all 32 locations
View Trial Details
Active, Not Recruiting

Evorpacept (ALX148) in Combination With Pembrolizumab and Chemotherapy in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-04)

NCT04675333

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
Locations
  • Hoag Hospital Irvine, California, United States
  • University of California San Diego La Jolla, California, United States
  • Cedar Sinai Medical Center Los Angeles, California, United States
  • University of Miami, Sylvester Comprehensive Cancer Center Miami, Florida, United States
View all 44 locations
View Trial Details
Active, Not Recruiting

Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)

NCT04675294

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +7 more
Locations
  • Hoag Hospital Irvine, California, United States
  • University of California San Diego La Jolla, California, United States
  • H. Lee Moffitt Cancer Center Tampa, Florida, United States
  • Northwest Georgia Oncology Centers Marietta, Georgia, United States
View all 53 locations
View Trial Details
Active, Not Recruiting

Selective Avoidance of Nodal VolumEs at Minimal Risk (GCC 20110)

NCT04609280

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +14 more
Locations
  • Maryland Proton Treatment Center Baltimore, Maryland, United States
  • UMMC Baltimore, Maryland, United States
  • University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States
  • Upper Chesapeake Health Bel Air, Maryland, United States
View Trial Details

Related conditions